4//SEC Filing
Singh Shawn 4
Accession 0001415889-24-000344
CIK 0001411685other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:17 PM ET
Size
11.0 KB
Accession
0001415889-24-000344
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2023-12-29$1.72/sh+167$287→ 5,633 total
Holdings
- 20,875(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan.
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001412071
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:17 PM ET
- Size
- 11.0 KB